Araris Biotech
Araris Biotech is a developer of an antibody-drug conjugates (ADCs founded in 2019.
2
Funding Rounds
$24.1m
Money raised
Overview
Araris Biotech is a developer of an antibody-drug conjugates (ADCs founded in 2019.
- Website:
- Business model: B2B
- Headquarters: Zürich
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Araris Biotech has raised a total of $24.11m in funding over 2 rounds.
Key Insights:
- Araris Biotech September 2022 Series A Funding Round: $24m
- Araris Biotech June 2019 Pre-Seed Funding Round: $110k
Araris Biotech September 2022 Series A Funding Round
$24m
Araris Biotech June 2019 Pre-Seed Funding Round
$110k